Top Genetic Testing Startups in 2024

Color makes data-driven health programs such as clinical genetics accessible, convenient, and cost-effective for everyone. Color partners with leading health systems, premier employers, and national health initiatives around the world including the million-person All of Us program by the National Institutes of Health. Rock Health has recognized Color as the “Best Digital Health Company to Work For.” We are committed to building an inclusive and diverse team that helps make precision health programs accessible, convenient, and cost effective for everyone. For more information about Color, visit color.com.

Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive karius® test that helps clinicians make rapid treatment decisions. our laboratory is clia-certified and cap-accredited to perform high-complexity clinical laboratory testing. we provide unique genomic insights by detecting microbial cell-free dna (mcfdna) circulating in the bloodstream from pathogens causing an acute infection. proprietary technology efficiently extracts mcfdna directly from blood and depletes the strong human background signal and environmental contaminants. advanced machine learning algorithms allow analysis of complex genomic data in real-time. proprietary reference genome databases are constantly refined as more data becomes available.

Synthego’s vision is to turn biology into an information science, with the ultimate goal of dramatically extending the healthy human lifespan. Synthego builds advanced bioinformatics and automated hardware platforms to create next-generation molecular biology tools, starting with full-stack genome engineering. These world-class tools accelerate basic scientific discovery, critical disease cures and novel synthetic biology applications to improve and prolong life.

Helix is a growth stage company focused on personal genomics. Helix has a simple but powerful mission: to empower every person to improve their life through DNA. We’re creating an ecosystem where people can explore diverse and uniquely personalized applications provided by high-quality partners. Helix handles sample collection, DNA sequencing, and secure data storage so that our partners can develop on-demand products in areas such as health, fitness, nutrition, lifestyle, genealogy, and inherited traits. Helix is headquartered in the San Francisco Bay Area and operates one of the world’s largest next-generation sequencing laboratories in San Diego. You can learn more at helix.com or follow @my_helix.

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies. The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology

10x Genomics (NASDAQ: TXG) is one of the fastest growing biotech companies, growing from $3M in revenue in 2015 to $240M in 2019. We create hardware, chemistry, and software that accelerates biological research. Our products are used by scientists around the world, including 96 of the top 100 global research institutions. Our mission is to build products that will be used throughout the rest of this century, to better understand, and eventually conquer disease. Behind every breakthrough is an extensive network of talented individuals contributing their unique perspectives, backgrounds, and areas of expertise. This kind of collaboration is essential to building a strong and effective workplace, and it’s our goal to create an inclusive environment that reflects the diversity of the communities and the goals that we serve. The discoveries we make now, as a team, will lead to better technologies, better treatments, and a better future.

We are a healthcare and biotech company specialising in personalised, genetics-based solutions for chronic conditions such as weight management, mental health, hormonal imbalances, ADHD, and more. Operating across Australia, New Zealand, and the Polynesian islands, we utilize advanced genetic testing and biotechnology to provide insights into pharmacogenetics, nutrigenomics, and metabolic health, helping patients take control of their well-being. Our experienced team of doctors, nurse practitioners, geneticists and dietitians work with patients to create individualized treatment plans that address their unique health needs. By combining genetic data with the latest in biotechnology, we offer targeted, science-driven care that tackles the root causes of chronic health issues. At Nume, we take a proactive approach to healthcare, using AI and genetic insights to deliver personalized programs. These programs include everything from medical treatments and lifestyle modifications to nutrition plans, all designed for long-term health improvement. Whether patients are seeking help with weight loss, managing mental health challenges, or addressing chronic hormonal conditions, we provide comprehensive solutions that are both effective and sustainable. Our telehealth platform makes healthcare more accessible than ever, offering video consultations that bring expert care directly to patients’ homes. By eliminating the need for in-person visits, we ensure that people across Oceania can easily access top-tier, ongoing healthcare, regardless of their location. Nume is at the forefront of integrating biotech with personalized care. We are committed to making healthcare more accessible, compassionate, and effective, driven by innovation and grounded in science. Our mission is to empower individuals with the knowledge and tools to lead healthier lives through cutting-edge, research-based solutions.

Our first products are a digital personalisation engine that recommends contraception types and brands based on our proprietary algorithm and a genetic test that can identify a woman's specific risks and predispositions. Our mission is to revolutionise how women decide about their contraception, empowering them to make the most suitable choice to their preference and unique biology. Our customers are all women of reproductive age (15-49). Women already using contraception but are dissatisfied, deciding for the first time, or had their life circumstances changed. (eg. pregnancy, relationship changes). Another key customer persona is parents helping their daughters choose contraception. Our partners will involve clinics and telehealth companies as personalised contraception prescribing will enable them to provide higher quality care at reduced costs.

There is a big gap between the innovations humanity has already come up with and what is available to patients for diagnostics and treatment. This gap is largely caused by a high degree of regulation which is needed to ensure patient safety. At Platomics, it is our mission to cut the gap between the technology humanity has at its disposal and what we can offer to patients - from currently up to 10 years down to 2 years and less.